ArticleScience advances2021
Regulation of telomere homeostasis and genomic stability in cancer by
Open access · goldAbstract read
In one paragraph
Article in Science advances, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.
0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed
4.5field-weighted citation impact, top 4% of its field
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
26 citing papers in PubMed, 43 citations in OpenAlex.
- The Role of NMedComm · 2026Review
- METTL3 in esophageal cancer: Current insights into molecular mechanisms, subtype heterogeneity and targeted therapy prospects (Review).International journal of oncology · 2026Review
- Epitranscriptomic control of telomere maintenance.Molecular biology reports · 2026Review
- NNature cell biology · 2026Article
- Circular RNA circCD44 targets methyltransferase-like 3/homeobox containing 1 to facilitate esophageal squamous cell carcinoma progression.The Kaohsiung journal of medical sciences · 2025Article
- Exploring the methyl-verse: Dynamic interplay of epigenome and m6A epitranscriptome.Molecular therapy : the journal of the American Society of Gene Therapy · 2025Review
- Effect of SNORD113-3/ADAR2 on glycolipid metabolism in glioblastoma via A-to-I editing of PHKA2.Cellular & molecular biology letters · 2025Article
- Ensartinib in a primary pulmonaryFrontiers in medicine · 2025Article
- N6-methyladenosine RNA landscape in the aged mouse hearts.Frontiers in cardiovascular medicine · 2025Article
- The role of N(6)-methyladenosine (m6a) modification in cancer: recent advances and future directions.EXCLI journal · 2025Review
- Regulatory roles of N6-methyladenosine (mCancer gene therapy · 2024Review
- Recruitment of the mGenome biology · 2024Article
- Functions and mechanisms of RNA mInternational journal of oncology · 2024Review
- Progression of mCell death discovery · 2024Review
- High N6-methyladenosine-activated TCEAL8 mRNA is a novel pancreatic cancer marker.Cancer science · 2024Article
- Von Hippel Lindau tumor suppressor controls m6A-dependent gene expression in renal tumorigenesis.The Journal of clinical investigation · 2024Article
- Current insights on m6A RNA modification in acute leukemia: therapeutic targets and future prospects.Frontiers in oncology · 2024Review
- Strong associations of telomere length and mitochondrial copy number with suicidality and abuse history in adolescent depressed individuals.Molecular psychiatry · 2023Article
- Methylation across the central dogma in health and diseases: new therapeutic strategies.Signal transduction and targeted therapy · 2023Review
- TERT mutations-associated alterations in clinical characteristics, immune environment and therapy response in glioblastomas.Discover oncology · 2023Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
25 authors at 7 institutions in 4 countries.
Ji Hoon LeeDepartment of Molecular Medicine, University of Texas Health Science Center at San Antonio, San Antonio, TX 78229, USA.ORCID http://orcid.org/0000-0002-7488-3999
Juyeong HongDepartment of Molecular Medicine, University of Texas Health Science Center at San Antonio, San Antonio, TX 78229, USA.ORCID http://orcid.org/0000-0001-6383-8474
Zhao ZhangDepartment of Molecular Medicine, University of Texas Health Science Center at San Antonio, San Antonio, TX 78229, USA.ORCID http://orcid.org/0000-0002-3679-8945
Bárbara de la Peña AvalosDepartment of Biochemistry and Structural Biology, University of Texas Health San Antonio, San Antonio, TX 78229, USA.ORCID http://orcid.org/0000-0001-9796-8015
Cecilia J ProiettiLaboratory of Molecular Mechanisms of Carcinogenesis and Molecular Endocrinology, Instituto de Biología y Medicina Experimental (IBYME), CONICET, Buenos Aires C1428ADN, Argentina.ORCID http://orcid.org/0000-0001-5875-4540
Agustina Roldán DeamicisLaboratory of Molecular Mechanisms of Carcinogenesis and Molecular Endocrinology, Instituto de Biología y Medicina Experimental (IBYME), CONICET, Buenos Aires C1428ADN, Argentina.ORCID http://orcid.org/0000-0002-9129-7246
Pablo Guzmán GDepartamento de Anatomía Patológica (BIOREN), Universidad de La Frontera, Temuco Casilla 54-D, Chile.ORCID http://orcid.org/0000-0001-5741-3584
Hung-Ming LamDepartment of Urology, University of Washington, Seattle, WA 98195, USA.
Jose GarciaDepartment of Urology, University of Washington, Seattle, WA 98195, USA.
Martine P RoudierDepartment of Urology, University of Washington, Seattle, WA 98195, USA.
Anthony E SiskDepartment of Pathology, David Geffen School of Medicine, University of California at Los Angeles, Los Angeles, CA 90095, USA.ORCID http://orcid.org/0000-0001-7262-3985
Richard De La RosaDepartment of Molecular Medicine, University of Texas Health Science Center at San Antonio, San Antonio, TX 78229, USA.ORCID http://orcid.org/0000-0001-9611-1060
Kevin VuDepartment of Medical Education, Joe R. and Teresa Lozano Long School of Medicine, San Antonio, TX 78229, USA.ORCID http://orcid.org/0000-0002-1288-147X
Mei YangDepartment of Molecular Medicine, University of Texas Health Science Center at San Antonio, San Antonio, TX 78229, USA.
Yiji LiaoDepartment of Molecular Medicine, University of Texas Health Science Center at San Antonio, San Antonio, TX 78229, USA.
Jessica ScheirerDepartment of Molecular Medicine, University of Texas Health Science Center at San Antonio, San Antonio, TX 78229, USA.ORCID http://orcid.org/0000-0003-3882-7604
Douglas PechacekDepartment of Molecular Medicine, University of Texas Health Science Center at San Antonio, San Antonio, TX 78229, USA.ORCID http://orcid.org/0000-0002-5279-9972
Pooja YadavDepartment of Cell Systems and Anatomy, University of Texas Health Science Center at San Antonio, San Antonio, TX 78229, USA.
Manjeet K RaoDepartment of Cell Systems and Anatomy, University of Texas Health Science Center at San Antonio, San Antonio, TX 78229, USA.ORCID http://orcid.org/0000-0001-7573-2677
Siyuan ZhengGreehey Children's Cancer Research Institute, University of Texas Health Science Center at San Antonio, San Antonio, TX 78229, USA.
Teresa L Johnson-PaisDepartment of Urology, University of Texas Health Sciences Center at San Antonio, San Antonio, TX 78229, USA.ORCID http://orcid.org/0000-0001-7580-1206
Robin J LeachMays Cancer Center, UT Health San Antonio MD Anderson, San Antonio, TX 78229, USA.ORCID http://orcid.org/0000-0002-3201-5579
Patricia V ElizaldeLaboratory of Molecular Mechanisms of Carcinogenesis and Molecular Endocrinology, Instituto de Biología y Medicina Experimental (IBYME), CONICET, Buenos Aires C1428ADN, Argentina.ORCID http://orcid.org/0000-0002-5923-9898
Eloïse DrayDepartment of Biochemistry and Structural Biology, University of Texas Health San Antonio, San Antonio, TX 78229, USA.ORCID http://orcid.org/0000-0001-6793-9838
Kexin XuDepartment of Molecular Medicine, University of Texas Health Science Center at San Antonio, San Antonio, TX 78229, USA. xuk3@uthscsa.edu.ORCID http://orcid.org/0000-0002-2850-2083
The University of Texas Health Science Center at San Antonio · USExperimental Medicine and Biology Institute · ARThe University of Texas MD Anderson Cancer Center · USUniversity of Washington · USHospital Clínico Universitario Lozano Blesa · ESUniversidad de La Frontera · CLUniversity of California, Los Angeles · US
Funding
TISSUE CULTURE---COREP30CA054174 · NCI · UNIVERSITY OF TEXAS HLTH SCIENCE CENTER · PI Lei Zheng · 1991 to 2026
$59.1MNCI NIH HHS P30 CA054174
Abstract
The role of RNA methylation on
Identifiers
What OpenQuestion holds
Textmetadata
LicenceCC BY-NC
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.